Mandate

Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB

Diagnostiskt Centrum Hud, the leading provider of medical dermatology services in Sweden, partnered with Bridgepoint Growth to further support the company’s expansion.

Today DCH operates six clinics across four Swedish cities and is the clear market leader in Sweden.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Michaela Cronemyr, Elsie Nassar, Ellinor Wargenbrant and Olivia Belding (M&A) and Sara Strandberg (employment), Lisa Hörnqvist (commercial agreements) and Tove Lövgren Frisk (corporate, crime & compliance).

Related

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026

Vinge advises PPI Public Property Invest AB (publ) in connection with cross-border merger and listing on Nasdaq Stockholm and Euronext Oslo Børs

Vinge has advised PPI Public Property Invest AB (publ) (“PPI”) in connection with its listing on Nasdaq Stockholm and secondary listing on Euronext Oslo Børs. The listing was carried out through a cross-border merger whereby PPI absorbed Public Property Invest ASA, whose shares were previously listed on Euronext Oslo Børs.
May 20, 2026

Vinge represents Triton in connection with the sale of Aleris

Vinge has represented Triton in connection with the sale of Aleris to Mehiläinen Group.
May 18, 2026